Last edition
News about "atherosclerotic cardiovascular disease"
Merck Signs Exclusive License Deal for HRS-5346 with Hengrui Pharma
Under the agreement, Hengrui Pharma has granted Merck exclusive rights to develop, manufacture and commercialize HRS-5346 worldwide, excluding Greater China region.
Atherosclerotic Cardiovascular Disease | 26/03/2025 | By Aishwarya | 106
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members